tion of women in research studies of coronary disease. The National Heart, Lung, and Blood Institute (NHLBI) Percutaneous Transluminal Coronary Angioplasty (PTCA) Registry included all consecutive cases, women and men, of initial coronary angioplasty at 16 clinical sites during a 10-month period in 1985-1986. One fourth of the registry population were women.
A decade ago, women undergoing coronary artery bypass graft surgery (CABG) were shown to be at higher risk for mortality than were men. Some but not University of Pittsburgh, and the protocol was approved by the University of Pittsburgh School of Medicine Internal Review Board.
The entire 1985-1986 registry cohort included 2,431 patients, of whom 295 had PTCA within 10 days of acute myocardial infarction (AMI). Publications3'4 from the registry that reported on 1,802 patients excluded the AMI patients and excluded patients from one site (Emory University) that had incomplete data at the time of the analysis. The current report also excludes AMI cases but includes additional patients from Emory, so the cohort of this study comprised 2,136 patients, of whom 546 were women. Four-year follow-up data were available on 95% of the cohort.
Registry definitions of success and complications established during the original period of See p 1030 classification system was used to grade stable exertional angina ranging from class I (mild) to class IV (severe). Class V was used for stable, nonexertional angina. Complete revascularization was defined as all lesions reduced to <50%. Men and women were compared according to baseline medical history and coronary artery disease presentation, risk factors, procedural characteristics, initial success and complications, and 4-year clinical course after PTCA. Logistic regression using maximum likelihood estimation was used to model the log odds of in-hospital death and MI. Explanatory variables considered for the models were baseline characteristics that had different distributions in men and women, such as age and history of congestive heart failure. Each such variable was then examined to see if it was related to outcome, e.g., in-hospital mortality. Variables that differed between men and women and were related to adverse outcome were included in a multivariate model. Those that were not independently related to outcome were eliminated, so the final model included variables that were significant, independent predictors. Coefficients were transformed to the odds scale for interpretation as an estimate of the risk of an event in women relative to the risk of the event in men. Cox regression analysis was used to compare 4-year survival rates of men and women with adjustment for baseline characteristics that were distributed differently between men and women and were related to outcome.
Further analysis was performed to determine the relation between body size and complications. Mechanical manipulation, whether PTCA or CABG, presumably is more difficult with smaller arteries. Because women are on average smaller, body size could account for procedures being more difficult among women. For men and women, outcomes were compared according to height, weight, body mass index (weight in kilograms divided by height in meters squared) and body surface Women and men had similar manifestations of angiographically defined coronary artery disease. More than half of the patients had multivessel disease. Left dominance was less prevalent in women. Fewer women than men had impaired left ventricular function with ejection fraction of <50% in 14% of the women compared with 21% of the men. This corresponds to the difference in the reported prior MIs. As presented in Table 2 , the baseline angiographic details of attempted lesions, such as severity of stenosis, geometry, collateral flow distal to the lesion, calcium in stenosis, proximal location, and presence of thrombus, were similar for women and men. Women tended to have more attempts in the right coronary artery and fewer in the left circumflex. Women's lesions were more likely to be judged tubular or diffuse rather than multiple discrete compared with men's lesions. The differences in complication rates were further studied to determine if the differences in distributions of other baseline characteristics between women and men in the registry, such as age and medical history, could account for the apparent differences by sex. Long-term Results Figure 1 presents a 4-year survival curve comparing men and women. The difference in mortality at baseline (-3%) is maintained throughout the follow-up period. However, by 4 years, the curves begin to diverge, with women having a mortality rate >4% greater than that of men. percent of women and 18% of men reported angina at 4 years (p<0.001). Of the patients with angina, 71% women and 64% men reported less severe angina compared with before first PTCA; thus, the percentages of patients who were either asymptomatic or had less severe angina at 4 years compared with before first PTCA were comparable by sex (91% of women versus 94% of men). In terms of the combination of major clinical events with symptomatic status at 4 years, 63% of women and 77% of men were alive and asymptomatic at 4-year follow-up. Fifty-one percent of women and 59% of men were alive and free of MI, CABG, and angina. The higher rates in women could be accounted for by the higher initial rates of mortality and by the higher rates of angina in women. Ninety-seven percent of the women and 94% of the men were using one or more cardiac medications at 4 years (p<0.05). More women than men were using maintenance therapy ((3-blockers, calcium channel blockers, or long-acting nitrates), but fewer women than men were using aspirin.
As presented in Table 7 , 10.8% of women and 6.6% of men had died by 4 years after initial PTCA. The differences in distributions of baseline risk factors by sex were examined to determine whether they would explain the difference in 4-year mortality between women and men. Adjustment for baseline characteristics associated with time to death (e.g., age, history of congestive heart failure, vessel disease, severe concomitant noncardiac disease, and inoperable or high-risk surgical candidate status) revealed that unlike during the periprocedural phase, sex was no longer an independent risk factor for 4-year mortality when the effects of the other risk factors were considered. Differences in angina at 4 years and in the combined event of death, MI, CABG, or angina at 4 years were also examined with multivariate analysis. Women had significantly higher rates of angina than men even after adjustment was made for age, time since first chest pain, family history of coronary heart disease, prior infarction, and new-onset angina. The rate of the combined events and angina end point at 4 years was significantly higher in women than in men (49% versus 40%) but was not significant after adjustment for other risk factors. Discussion A recent article5 reports that for patients hospitalized for coronary heart disease in Massachusetts and Maryland, women were much less likely than men to undergo cardiac catheterization or revascularization procedures. The Survival and Ventricular Enlargement Investigators6 recently observed that among patients hospitalized for MI with resultant low ejection fraction, women were less likely than men to have undergone prior catheter- (1978) (1979) (1980) (1981) , shorter men (<165 cm) had a mortality rate comparable to that of women overall and greater than the mortality rate of taller men. 9 No relation between body size and mortality was found for women in the early cohort. In the 1985-1986 cohort, rates of procedural complications were related to height for both men and women. The shorter the person was, the more likely there were to be complications, and short women compared with tall women had somewhat higher mortality. In contrast, rates of angiographic success were actually higher in women. Measures of body size other than height were not related to success or complications. These results suggest that small arteries in women may no longer be a serious problem. The probable explanation is that technical equipment improvements have allowed smaller arteries to be successfully dilated, and operator experience allows selection of appropriate-sized arteries.
Long-term outcome after PTCA is different for women than for men in that they have slightly fewer events -MI, repeat PTCA, and/or CABG -but they are much more likely to report angina and use of medications. Similar findings regarding symptoms after CABG have been reported.10 However, after PTCA, the angina experienced by women is generally less severe than at baseline, so almost as many women as men report that their symptomatic status has improved even though some angina may be present.
In the early PTCA Registry cohort (1977) (1978) (1979) (1980) (1981) , there was a lower angiographic success rate for women (60%) than for men (66%), and complications and mortality rates were higher in women.9 The long-term success, however, was as good or better than that of men. In a series of PTCAs between 1980 and 1986 in 2,727 men and 969 women reported by McEniery et al,1l the results of the procedures for men and women were remarkably similar. In that series, women were threefold as likely to die, but there were so few deaths that this difference was not statistically significant.
In conclusion, women undergoing PTCA have a higher procedural mortality risk that is explained partly, but not entirely, by their worse cardiovascular risk factor profile. Otherwise, the success rate and long-term prognosis after PTCA are excellent and should be considered for women in need of revascularization.
